Form 4 for FULC Fulcrum Therapeutics, Inc.
Accepted 2021-08-12 00:00:00 ET · period of report 2021-08-10 · accession 0000899243-21-032753 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-12 | 2021-08-10+ | FULC | Stuart Bryan | See Remarks, Dir | M - OptEx | $7.84 | +60.0K | 32.0K | New | +$470.4K |
| DM | 2021-08-12 | 2021-08-10+ | FULC | Stuart Bryan | See Remarks, Dir | S - Sale+OE | $20.42 | -60.0K | 0 | -100% | -$1.23M |
| DM | 2021-08-12 | 2021-08-10+ | FULC | Stuart Bryan | See Remarks, Dir | M - OptEx | $0.00 | -60.0K | 271.6K | -18% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-11 | M | A | 28,000 | $7.84 | 28,000 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-10 | S | D | 32,000 | $17.50 | 0 | D | — | — | |
| 3 | Common | Common Stock | 2021-08-10 | M | A | 32,000 | $7.84 | 32,000 | D | — | — | |
| 4 | Common | Common Stock | 2021-08-11 | S | D | 28,000 | $23.75 | 0 | D | — | — | |
| 5 | Derivative | Stock Option (right to buy) | 2021-08-11 | M | D | 28,000 | $0.00 | 243,571 | D | $7.84 · — to 2028-12-17 | 28,000 Common Stock | (F2) This option was granted on December 18, 2018 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of December 18, 2018. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service. |
| 6 | Derivative | Stock Option (right to buy) | 2021-08-10 | M | D | 32,000 | $0.00 | 271,571 | D | $7.84 · — to 2028-12-17 | 32,000 Common Stock | (F2) This option was granted on December 18, 2018 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of December 18, 2018. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service. |